申请人:NeuroSearch A/S
公开号:US20010018444A1
公开(公告)日:2001-08-30
Compounds of formula (a), (b), (c), or (d), or any mixture thereof, or a pharmaceutically-acceptable salt thereof;
1
wherein R is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl or 2-hydroxyethyl; R
3
is —CH
2
—X—R′, wherein X is O, S or NR″, wherein R″ is hydrogen or alkyl and R′ is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, or —CO-alkyl; R
4
is phenyl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; 3,4-methylenedioxyphenyl; benzyl optionally substituted with halogen, CF
3
, CH, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; heteroaryl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl; or naphthyl optionally substituted with halogen, CF
3
, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl, or aryl. The compounds are monoamine neurotransmitter, i.e., dopamine, serotonin, noradrenaline, reuptake inhibitors.
公式为(a),(b),(c)或(d)的化合物,或其任何混合物,或其药学上可接受的盐; 其中R是氢,烷基,烯基,炔基,环烷基,环烷基烷基或2-羟乙基; R3为-CH2-X-R',其中X为O,S或NR",其中R"为氢或烷基,R'为烷基,烯基,炔基,环烷基,环烷基烷基或-CO-烷基; R4为苯基,可选择用卤素,CF3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂环芳基或芳基取代; 3,4-亚甲二氧基苯基; 苄基,可选择用卤素,CF3,CH,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂环芳基或芳基取代; 杂环芳基,可选择用卤素,CF3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂环芳基或芳基取代; 或萘基,可选择用卤素,CF3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂环芳基或芳基取代。这些化合物是单胺神经递质,即多巴胺,5-羟色胺,去甲肾上腺素,再摄取抑制剂。